CID 16131955

Hiv-1 12-mer tar rna containing 2'-o-methyl and 2',4'-locked nucleotides: 5'-[2'-ome(c')-2'-ome(u)-2'-ome(c)-2'-ome(c)-2'-ome(g)-lna(c)-2'-ome(a)-2'-ome(g)-lna(c)-2'-ome(u)-lna(c)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C154H190N44O92P12
SMILES
CC1=CN(C(=O)N=C1N)C2C3C(C(O2)(CO3)COP(=O)(O)OC4C(OC(C4OC)N5C=NC6=C5N=C(NC6=O)N)COP(=O)(O)OC7C(OC(C7OC)N8C=NC9=C(N=CN=C98)N)COP(=O)(O)OC1C2C(OC1(CO2)COP(=O)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(O)OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=O)(O)OC1C(OC(C1OC)N1C=C(C(=NC1=O)N)C)COP(=O)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)COP(=O)(O)OC1C(OC(C1OC)N1C=C(C(=NC1=O)N)C)CO)N1C=C(C(=NC1=O)N)C)OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=O)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C(N=CN=C31)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC3=C(C=C1)C(=O)OC31C3=C(C=C(C=C3)O)OC3=C1C=CC(=C3)O)C(O2)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C154H190N44O92P12/c1-58-32-190(146(212)178-113(58)156)131-98(241-6)89(73(37-199)266-131)279-292(219,220)254-38-75-91(100(243-8)129(268-75)188-26-22-83(202)176-144(188)210)282-293(221,222)256-40-77-93(102(245-10)132(270-77)191-33-59(2)114(157)179-147(191)213)283-295(225,226)255-39-74-90(99(242-7)128(267-74)187-25-21-82(155)175-143(187)209)281-294(223,224)257-41-78-96(105(248-13)135(273-78)197-56-172-87-123(197)183-141(164)185-126(87)206)286-301(237,238)264-51-153-48-252-109(139(277-153)194-36-62(5)117(160)182-150(194)216)112(153)290-299(233,234)261-45-81-95(104(247-12)134(272-81)196-55-171-86-119(162)167-53-169-122(86)196)284-296(227,228)258-42-79-97(106(249-14)136(274-79)198-57-173-88-124(198)184-142(165)186-127(88)207)287-302(239,240)263-50-152-47-251-107(137(276-152)192-34-60(3)115(158)180-148(192)214)110(152)288-297(229,230)259-43-76-92(101(244-9)130(269-76)189-27-23-84(203)177-145(189)211)285-300(235,236)262-49-151-46-250-108(138(275-151)193-35-61(4)116(159)181-149(193)215)111(151)289-298(231,232)260-44-80-94(103(246-11)133(271-80)195-54-170-85-118(161)166-52-168-121(85)195)280-291(217,218)253-28-24-70(120(163)204)174-125(205)63-15-18-66-69(29-63)154(278-140(66)208)67-19-16-64(200)30-71(67)265-72-31-65(201)17-20-68(72)154/h15-23,25-27,29-36,52-57,70,73-81,89-112,128-139,199-201H,24,28,37-51H2,1-14H3,(H2,163,204)(H,174,205)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H,239,240)(H2,155,175,209)(H2,156,178,212)(H2,157,179,213)(H2,158,180,214)(H2,159,181,215)(H2,160,182,216)(H2,161,166,168)(H2,162,167,169)(H,176,202,210)(H,177,203,211)(H3,164,183,185,206)(H3,165,184,186,207)/t70-,73?,74?,75?,76?,77?,78?,79?,80?,81?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,109?,110?,111?,112?,128?,129?,130?,131?,132?,133?,134?,135?,136?,137?,138?,139?,151?,152?,153?/m0/s1
InChIKey
FDJYWZFNCYMEAG-LWDAAPTCSA-N
Compound name
[3-[[3-[[3-[[3-[[7-[[3-[[3-[[7-[[3-[[7-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methyl [5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4498.8394 Da
Monoisotopic Mass

-29.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4499.8467 313.1
[M+Na]+ 4521.8286 313.5
[M-H]- 4497.8321 313.2
[M+NH4]+ 4516.8732 313.2
[M+K]+ 4537.8026 313.1
[M+H-H2O]+ 4481.8367 312.7
[M+HCOO]- 4543.8376 313.1
[M+CH3COO]- 4557.8533 313.1
[M+Na-2H]- 4519.8141 313.6
[M]+ 4498.8389 313.3
[M]- 4498.8399 313.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.